Hepatocellular carcinoma (HCC) is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulative function. Surgical resection is the best option to cure HCC, however, surgery on cirrhotic liver may increase the risk of bleeding. Despite the clinical relevance of the matter, no guidelines are available on the administration of antithromboembolic prophylaxis in cirrhotic patients undergoing hepatic resection.
A research team from Italy have retrospectively addressed the issue of the real need for antithromboembolic prophylaxis in cirrhotic patients undergoing liver resection and proved that the risk of venous thromboembolism after hepatic resection in cirrhotic patients is low. Their study will be published on May 7, 2010 in the World Journal of Gastroenterology .
Image-Guided Treatment Could Prevent Long-Term Deep Venous Thrombosis (DVT) Complications
Image-guided interventional radiology procedures could improve long-term treatment in patients with Deep Venous Thrombosis (DVT).
Image-guided interventional radiology procedures could improve long-term treatment in patients with Deep Venous Thrombosis (DVT).
Prospective studies on a larger series of patients are warranted to clearly define which patients might benefit from antithromboembolic prophylaxis and which patients should avoid prophylaxis.
Study Links Hereditary Factors to Abdominal Venous Thrombosis
News study has found that hereditary and acquired risk factors play an important role in the clotting of blood in abdominal veins, known as abdominal venous thrombosis.
News study has found that hereditary and acquired risk factors play an important role in the clotting of blood in abdominal veins, known as abdominal venous thrombosis.
TAN
Gene That Causes Cerebral Venous Thrombosis Identified
Scientists have identified a new gene, factor XII C46T, linked to cerebral venous thrombosis, a condition that causes blood clots in the veins of the brain that leading to stroke.
Scientists have identified a new gene, factor XII C46T, linked to cerebral venous thrombosis, a condition that causes blood clots in the veins of the brain that leading to stroke.
Genetic Variations Associated With Risk of Venous Thrombosis Identified
Researchers have identified new genetic variations that may be associated with the risk of developing nonfatal venous thrombosis in postmenopausal women
Researchers have identified new genetic variations that may be associated with the risk of developing nonfatal venous thrombosis in postmenopausal women
